ArticleExperimental biology and medicine (Maywood, N.J.)2019

LCZ696, an angiotensin receptor-neprilysin inhibitor, ameliorates diabetic cardiomyopathy by inhibiting inflammation, oxidative stress and apoptosis.

Qing Ge et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.